Acadia Pharmaceuticals Announces DAYBUE® STIX (trofinetide) is Now Broadly Available in the United States for the Treatment of Rett Syndrome April 7, 2026 anxiety ONLY AVAILABLE IN PAID PLANS. Originally reported by biospace. Read more Source: https://www.biospace.com/press-releases/acadia-pharmaceuticals-announces-daybue-stix-trofinetide-is-now-broadly-available-in-the-united-states-for-the-treatment-of-rett-syndrome
